213 related articles for article (PubMed ID: 24218296)
1. Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes.
Krolewski AS; Gohda T; Niewczas MA
Clin Exp Nephrol; 2014 Aug; 18(4):571-83. PubMed ID: 24218296
[TBL] [Abstract][Full Text] [Related]
2. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
Krolewski AS; Skupien J; Rossing P; Warram JH
Kidney Int; 2017 Jun; 91(6):1300-1311. PubMed ID: 28366227
[TBL] [Abstract][Full Text] [Related]
3. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
[TBL] [Abstract][Full Text] [Related]
4. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.
Krolewski AS
Diabetes Care; 2015 Jun; 38(6):954-62. PubMed ID: 25998286
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.
Skupien J; Warram JH; Smiles AM; Stanton RC; Krolewski AS
Diabetes Care; 2016 Dec; 39(12):2262-2269. PubMed ID: 27647852
[TBL] [Abstract][Full Text] [Related]
6. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline.
Krolewski AS; Bonventre JV
Semin Nephrol; 2012 Sep; 32(5):407-14. PubMed ID: 23062980
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
8. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
[TBL] [Abstract][Full Text] [Related]
9. Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
Colombo M; McGurnaghan SJ; Bell S; MacKenzie F; Patrick AW; Petrie JR; McKnight JA; MacRury S; Traynor J; Metcalfe W; McKeigue PM; Colhoun HM;
Diabetologia; 2020 Mar; 63(3):636-647. PubMed ID: 31807796
[TBL] [Abstract][Full Text] [Related]
10. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.
Niewczas MA; Mathew AV; Croall S; Byun J; Major M; Sabisetti VS; Smiles A; Bonventre JV; Pennathur S; Krolewski AS
Diabetes Care; 2017 Mar; 40(3):383-390. PubMed ID: 28087576
[TBL] [Abstract][Full Text] [Related]
11. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
12. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
13. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease.
Kim SJ; Smail N; Paraskevas S; Schiff J; Cantarovich M
Transplantation; 2014 Mar; 97(6):675-80. PubMed ID: 24637866
[TBL] [Abstract][Full Text] [Related]
14. Pancreas transplant as treatment to arrest renal function decline in patients with type 1 diabetes and proteinuria.
Cantarovich D; Perrone V
Semin Nephrol; 2012 Sep; 32(5):432-6. PubMed ID: 23062983
[TBL] [Abstract][Full Text] [Related]
15. [Developmental phases and diagnostic criteria in diabetic nephropathy].
Duława J
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):807-9. PubMed ID: 2096373
[No Abstract] [Full Text] [Related]
16. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
17. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
[TBL] [Abstract][Full Text] [Related]
18. Rapid decline of renal function in patients with type 2 diabetes with heavy proteinuria: a report of three cases.
Lim CTS; Nordin NZ; Fadhlina NZ; Anim MS; Kalaiselvam T; Haikal WZ; Goh BL
BMC Nephrol; 2019 Jan; 20(1):22. PubMed ID: 30651084
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
20. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
